http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015166042-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a94563ea41975bf2436137b0a043cbc |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 |
filingDate | 2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69170643ea0164169f89c9564bfa58b1 |
publicationDate | 2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2015166042-A1 |
titleOfInvention | Stilbene derivatives and their use for the treatment of cancer |
abstract | The present application relates to a compound of formula (I) wherein each of R 1 , R 2 , R 3 , R 4 or R 5 are independently selected from hydrogen, aliphatic, alkoxy, thioalkyl, alkylamino, halogen, hydroxy, cyano, nitro, hydroxyalkyl, alkylcarbonyloxy, alkoxycarbonyl, alkylcarbonyl, haloalkyi, alkylsulfonylamino NH 2 , NO 2 , SO 2 R x , SOR x and COOR x , where R x is hydrogen, aliphatic or aryl, for use in the prevention and/or treatment of cancer. The compounds are particularly provided for the prevention and/or treatment of hormone-induced cancers, such as breast, ovarian, uterine, endometrial and prostate cancer. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101935794-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018136792-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11261152-B2 |
priorityDate | 2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 600.